Mablink Bioscience

Araris Biotech

This company develops antibody-drug conjugate linker technology and targeted cancer therapies for pharmaceutical partners and patients.

Catena Bio

This biotechnology firm develops protein conjugation technology and multi-payload therapeutic conjugates for biopharmaceutical companies to treat oncology and autoimmune diseases.

Promatix

Promatix develops antibody-drug conjugates for cancer treatment using a proprietary multi-omics platform to identify and target specific tumour markers.

araris

This company develops antibody-drug conjugate linker technology to create targeted cancer therapies for the pharmaceutical and biotechnology industries.

Alphina Therapeutics

This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.

Callio Therapeutics

The company develops multi-payload antibody-drug conjugates to treat cancer patients.

Pinot Bio

The company develops antibody-drug conjugate platforms and targeted anticancer therapeutics for pharmaceutical firms and clinical-stage biotechnology partners.

CrossBridge Bio

This company develops dual-payload antibody-drug conjugates to treat solid tumors for healthcare providers and pharmaceutical partners.